Lung
Pulmonary tuberculosis
The classic granulomatous infection: Mycobacterium tuberculosis provokes granulomas with caseous necrosis. Primary infection is usually contained; reactivation or reinfection causes cavitating upper-lobe disease.
Causes and risk factors
- Mycobacterium tuberculosis, inhaled
- A third of the world’s population has been infected; only some develop active disease
- A weak or overwhelmed immune response allows spread (miliary tuberculosis)
Gross pathology
- Primary: the Ghon complex, a small subpleural granuloma in the mid lung with an involved hilar lymph node.
- Secondary (reactivation or reinfection): granulomas and cavities mainly in the upper lobes.
- Miliary: countless 2–4 mm granulomas, like millet seeds, throughout the lungs.
Under the microscope
- Granulomas of epithelioid macrophages with lymphocytes, plasma cells and fibroblasts.
- Langhans giant cells formed by macrophages stimulated by interferon-γ from T lymphocytes.
- Central caseous necrosis in larger granulomas.
How it develops
- Inhaled bacilli are taken up by macrophages; T cells (TH1) release interferon-γ, activating macrophages.
- Granulomas form to contain the infection; in most people primary infection stays subclinical and later calcifies.
- Reactivation or reinfection in adults causes upper-lobe granulomas whose caseous centres cavitate.
- With poor immunity, the bacilli spread through the blood: miliary tuberculosis in the lungs and other organs.
Complications
- Cavitation of the upper lobes
- Miliary spread to other organs
- Airway obstruction by enlarged hilar nodes in primary disease
Investigations
- Sputum smear and culture
- Acid-fast bacilli on Ziehl–Neelsen stain; culture confirms the organism and its drug sensitivity.
- Nucleic acid amplification test
- Detects Mycobacterium tuberculosis DNA, and rifampicin resistance, within hours.
- Chest radiograph
- Upper-lobe cavities in secondary tuberculosis, a Ghon complex in primary infection, countless small nodules in miliary disease.
- Tuberculin skin test or interferon-γ release assay
- Show infection, latent or active; they do not prove active disease.
- Biopsy
- Granulomas with caseous necrosis.
Drug treatment
- Antituberculosis drugs (isoniazid, rifampicin, pyrazinamide, ethambutol): A combination of drugs taken for months: tuberculosis grows slowly, hides in granulomas and macrophages, and becomes resistant to any single drug. Liver toxicity and drug interactions shape their use.
Drugs to avoid or use with care
- Inhaled corticosteroids (ICS) (Use with care): Corticosteroids suppress the cell-mediated immunity that contains mycobacteria.
- Systemic corticosteroids (glucocorticoids) (Use with care): They suppress the cell-mediated immunity that walls off mycobacteria in granulomas: tuberculosis can reactivate.
- TNF-α inhibitors (Contraindicated): Without TNF-α, granulomas break down and tuberculosis reactivates, often disseminated. Everyone is screened before starting.
Anatomy involved
Written from
- Robbins and Cotran Atlas of Pathology, 3rd ed., Ch. 5, The Lung, pp. 136–138, figs 5-79 to 5-87
Educational reference. Not medical advice, diagnosis or treatment.